Minnesota · 2025-2026 Regular Session · Bill
HF 1379: Use of nonopioid directives authorized, and immunity for certain acts or failures to act established.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HF 1379 is a bill introduced in the Minnesota House on February 24, 2025. According to its official title, it concerns: Use of nonopioid directives authorized, and immunity for certain acts or failures to act established. Primary sponsor: Dave Baker (Republican). It lists 7 additional sponsors. Most recent recorded action (March 27, 2025): Committee report, to adopt as amended and re-refer to Health Finance and Policy.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 4 · Republican 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Dave Baker | Primary sponsor | Republican | House | 16B |
| Jeff Backer | Co-sponsor | Republican | House | 9A |
| Kristin Bahner | Co-sponsor | Democratic-Farmer-Labor | House | 37B |
| Robert Bierman | Co-sponsor | Democratic-Farmer-Labor | House | 56A |
| Steve Elkins | Co-sponsor | Democratic-Farmer-Labor | House | 50B |
| Dawn Gillman | Co-sponsor | Republican | House | 17A |
| Bernie Perryman | Co-sponsor | Republican | House | 14A |
| Bianca Virnig | Co-sponsor | Democratic-Farmer-Labor | House | 52B |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Committee report, to adopt as amended and re-refer to Health Finance and Policy
- Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law
- Authors added Elkins, Bahner, and Perryman
- Author added Backer
- Author added Virnig
- Introduction and first reading, referred to Health Finance and Policy